Skip to main content
. 2012 Dec 13;2012:147863. doi: 10.1155/2012/147863

Figure 2.

Figure 2

Curcumin's effects on AKT/MTOR and ERK pathways in vitro. (a) Western blot of SRB12-p9 tumor cells treated with (+) or without (−) 20 μM curcumin for 24 hours and probed with the indicated antibody. Representative Western blots for two analyzed sets are shown. (b) Band densities of indicated biomarkers (n = 6) were quantified using ImageQuant software and normalized to actin protein level. Data presented as Mean ± SE. * Indicates P < 0.05 versus vehicle-treated control. A significant inhibition of expression of the following biomarkers was observed: pAKT (P = 0.0368); pS6 (P = 0.0182); p4EBP1 (P = 0.0098); pSTAT3 (P < 0.0001); pERK1/2 (P = 0.0313). a.u.: arbitrary units.